Skip to main content
2025 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Ananth Kumar Kammala, PhD (he/him/his)

Assistant Professor
The University of Texas Medical Branch
Galveston, Texas

Dr. Ananth Kumar Kammala is a Tenure-Track Assistant Professor in the Department of Obstetrics and Gynecology at the University of Texas Medical Branch (UTMB) at Galveston, where he directs the Molecular Pharmacology and Computational Lab. With a multidisciplinary background in pharmacology, immunology, and traditional medicine, Dr. Kammala’s research focuses on extracellular vesicle (EV)-based therapeutics for maternal-fetal medicine and neurodegenerative diseases.

Dr. Kammala leads multiple NIH-funded projects investigating innovative strategies to manipulate drug transport and immune signaling at the feto-maternal interface. His pioneering work demonstrated that trophoblast-derived EVs can naturally carry drug transporter proteins like P-glycoprotein, a finding that has opened new avenues for EV-based therapies in preterm birth and Alzheimer's disease. He also explores the use of exosome-loaded anti-inflammatory cytokines, such as IL-10, to mitigate fetal membrane inflammation.

Blending his expertise in transporter biology, exosome engineering, and pharmacokinetics, Dr. Kammala is recognized for his translational research aimed at developing personalized and physiologically relevant drug delivery systems. His work continues to bridge basic science with clinical impact in women’s health and neurological disorders.

Disclosure information not submitted.

Presentation(s):